Clinical trial
A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate…
NCT00480090 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00480090 |
|---|---|
| Title | A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer |
| Official title | A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer |
| Acronym | SLAP |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Cytarabine |
| Enrollment | 10 |
| Start date | Apr 1, 2007 |
| Primary completion | Oct 1, 2010 |
| Completion | Jul 1, 2011 |
| First posted | May 30, 2007 |
| Last update posted | Feb 15, 2019 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: